Clinical Trials in Baltimore

Showing 3561-3580 of 11,213 trials

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

NCT03246074

This research is being done to test the safety of the combination of the study drugs fostamatinib and paclitaxel. This study tests different doses of the drugs to see which doses are safest in people with ovarian cancer when given together.

Ovarian Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins35 participantsStarted Apr 2018

Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

NCT03277196

This is a Phase 3, 2-arm, multicenter study with an open-label ivacaftor arm and an observational arm to evaluate the safety and efficacy of long-term ivacaftor treatment in participants with cystic fibrosis (CF) who are \<24 months of age at treatment initiation and have an approved Ivacaftor-Responsive mutation.

Cystic Fibrosis

Vertex Pharmaceuticals Incorporated86 participantsStarted Aug 2017

Birmingham, Alabama, United States • Palo Alto, California, United States • Wilmington, Delaware, United States +26 more locations

Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer

A Study to Evaluate the Safety of Long-term Ivacaftor Treatment in Participants With Cystic Fibrosis Who Are Less Than 24 Months of Age at Treatment Initiation and Have an Approved Ivacaftor-Responsive Mutation

Find Trials by Condition in Baltimore

TriVerity in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections and Suspected Sepsis

Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus

Investigation of Clot in Ischemic Stroke and Hematoma Evacuation

Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab

Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings

Stress Management Training for Healthy Aging

Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Stockholm3 Validation Study in a Multi-Ethnic Cohort

A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms